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Abstract
Background: In temperate zones, all-cause mortality exhibits a marked seasonality, and one of the main causes of
winter excess mortality is influenza. There is a tradition of using statistical models based on mortality from
respiratory illnesses (Pneumonia and Influenza: PI) or all-cause mortality for estimating the number of deaths
related to influenza. Different authors have applied different estimation methodologies. We estimated mortality
related to influenza and periods with extreme temperatures in Denmark over the seasons 1994/95 to 2009/10.
Methods: We applied a multivariable time-series model with all-cause mortality as outcome, activity of influenza-
like illness (ILI) and excess temperatures as explanatory variables, controlling for trend, season, age, and gender.
Two estimates of excess mortality related to influenza were obtained: (1) ILI-attributable mortality modelled directly
on ILI-activity, and (2) influenza-associated mortality based on an influenza-index, designed to mimic the influenza
transmission.
Results: The median ILI-attributable mortality per 100,000 population was 35 (range 6 to 100) per season which
corresponds to findings from comparable countries. Overall, 88% of these deaths occurred among persons ≥ 65
years of age. The median influenza-associated mortality per 100,000 population was 26 (range 0 to 73), slightly
higher than estimates based on pneumonia and influenza cause-specific mortality as estimated from other
countries. Further, there was a tendency of declining mortality over the years. The influenza A(H3N2) seasons of
1995/96 and 1998/99 stood out with a high mortality, whereas the A(H3N2) 2005/6 season and the 2009 A(H1N1)
influenza pandemic had none or only modest impact on mortality. Variations in mortality were also related to
extreme temperatures: cold winters periods and hot summers periods were associated with excess mortality.
Conclusion: It is doable to model influenza-related mortality based on data on all-cause mortality and ILI, data that
are easily obtainable in many countries and less subject to bias and subjective interpretation than cause-of-death
data. Further work is needed to understand the variations in mortality observed across seasons and in particular
the impact of vaccination against influenza.
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Background
In temperate zones, all-cause mortality exhibits a marked
seasonality with the highest number of deaths in the
winter and a lower number in the summer period. The
reasons for this pattern are complex and not completely
understood. Many factors may contribute, including
increased rates of acute respiratory tract infections and
death from cardio-vascular diseases in the winter months,
periods with extreme temperature, and possibly mental
and physiological effects (e.g. D-vitamin) related to day-
light as well as social and psychological factors related to
Christmas and New Year holidays [1]. However, it is well
recognised that one of the main causes of winter excess
mortality is influenza.
There is a long tradition of using statistical models based
on mortality from respiratory illnesses (Pneumonia and
Influenza: PI) or all-cause mortality for estimating the
number of deaths related to influenza. Different authors
have applied different estimation methodologies. The
most commonly used methodology, often called Serflings
method, estimate the expected mortality without influenza
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influenza activity [2,3] or dynamically defined periods with
no influenza activity classified according to influenza activ-
ity recorded under a certain level e.g. 95% confidence
limit; data on influenza activity have been defined by influ-
enza specific mortality [4-7], or Influenza Like Illness (ILI)
reported from networks of sentinel practices [8-10] or
reported as surveillance counts for laboratory virus-posi-
tive specimens [11,7]. Hence, periods with influenza-attri-
butable mortality may vary from season to season
according to each season’s influenza activity. Excess mor-
tality attributable to influenza is then calculated as the
observed minus the modelled expected mortality without
influenza as estimated from periods without influenza
activity. Others has extended the estimation of the no-
influenza expected mortality to exclude impact of other
respiratory and circulatory diseases, like infections from
Respiratory Syncytial Virus (RSV), by controlling for pre-
sence of these in the estimation of the expected mortality
in the absence of influenza [9,11,12]. Instead of excluding
periods with influenza activity from the estimation of the
no-influenza expected mortality, these periods may be
down-weighted [13]. Alternatively, influenza activity can
be included directly as a parameter in a multivariable
time-series model, then often using an identity-link,
including influenza activity, trend and seasonal variation
as independent variables [14,3,11,15]. Thus, in this latter
approach excess mortality is determined directly from
data on influenza and not as a residual difference.
Ambient temperature may also play a role in the seaso-
nal variation of mortality [14,16-19], but this is often not
included in assessment of influenza-related mortality.
The aim of the present study was to describe mortality
associated to influenza and periods with extreme tempera-
tures in Denmark over the seasons 1994/95 to 2009/10.
Materials and methods
To investigate the impact of influenza and extreme tem-
peratures on mortality we specified and applied a multi-
variable time-series model with all-cause mortality as
outcome, influenza activity and excess temperatures as
explanatory variables, and controlled for trend, season,
age, and gender.
Data sources
Data for the analyses were obtained from the following
sources:
Individual notifications of deaths were obtained from
the Danish civil registry system by the Department of
Epidemiology, Statens Serum Institut (SSI), in the form
of daily electronic notifications of all deaths.
The sentinel influenza surveillance system based on
primary health care consultations was established in
1994 as a voluntary reporting system of general
practitioners providing weekly reports on the total num-
ber of consultations and age-specific numbers of Influ-
enza-Like-Illness (ILI) consultations to the Department
of Epidemiology, Statens Serum Institut (SSI). This sys-
tem is usually discontinued in the summer period
between week 20 and 40, but in 2009 data were col-
lected throughout the year.
Data on daily temperatures registered at Danish weather
stations was downloaded from the National Oceanic and
Atmospheric Administration Online Climate Data Direc-
tory [20]. Mean over daily temperatures from all weather
stations was used as the overall Danish temperature for
that day. Weekly temperatures were calculated as the
mean over the week, as was the weekly minimum and
maximum temperatures. Using the mean weekly tempera-
tures, we estimated the expected weekly temperature in a
General-Linear-Model with a sine seasonal variation
(Figure 1). Weeks with extreme temperatures was defined
by a threshold-linear model [21]. Warm weeks were
defined as weeks with weekly minimum temperature >
expected weekly temperature; cold weeks as weekly maxi-
mum temperature < expected weekly temperature and the
effect as the linear difference between observed and mini-
mum respectively maximum weekly temperature.
Size of the Danish population by age and gender on
the 1
st of January every year was downloaded from Sta-
tistics Denmark [22] (Table 1). The weekly sizes of the
age group and gender specific populations were achieved
by linear interpolation.
Analyses
In our primary analysis, termed ILI-attributable mortal-
ity, we fitted a model with the weekly all cause number
of death as outcome and ILI-activity and extreme tem-
peratures as independent variables and adjusted for
trend, seasonal variation, age and gender.
Influenza circulates simultaneously with other respira-
tory tract infections that may have been reported as ILI,
especially in autumn and spring, i.e. in the beginning
and end of the influenza season. To get an indication of
the part of ILI associated with mortality associated with
influenza we did a sub-analysis, where we reduced ILI in
the beginning and end of the period with activity; based
on the assumption that the major part of ILI will be
influenza at the peak whereas influenza will not be a
major contributor to ILI when ILI is low. This analysis
was termed influenza-associated mortality.
Statistical analyses
To estimate the association between weekly mortality,
and influenza activity and extreme temperatures for the
seasons 1994/5 to 2009/10 (week 27, 1994 to week 26,
2010), we used a multivariable time-series model with
calendar week (wk) as underlying time unit, stratified by
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Page 2 of 13Table 1 The Danish population and dominating influenza virus, by season
Season
1 Dominant
virus
Population (100,000)
All ages 0-4 years 5-14 years 15-64 years Aged 65
1994/95 H3N2 52.18 3.35 5.67 35.17 7.99
1995/96 H3N2 52.50 3.43 5.77 35.35 7.96
1996/97 H3N2 52.74 3.46 5.90 35.45 7.93
1997/98 H3N2 52.95 3.46 6.06 35.51 7.92
1998/99 H3N2 53.13 3.44 6.23 35.55 7.91
1999/00 H3N2 53.30 3.41 6.40 35.59 7.91
2000/01 H1N1 53.49 3.38 6.56 35.63 7.92
2001/02 H3N2 53.68 3.35 6.69 35.68 7.95
2002/03 H3N2 53.83 3.32 6.80 35.72 7.99
2003/04 H3N2 53.97 3.30 6.87 35.76 8.05
2004/05 H3N2 54.12 3.28 6.90 35.81 8.13
2005/06 H3N2 54.28 3.25 6.90 35.89 8.23
2006/07 H3N2 54.48 3.25 6.89 35.99 8.36
2007/08 H1N1 54.75 3.26 6.84 35.12 8.53
2008/09 H3N2 55.09 3.27 6.81 36.26 8.76
2009/10 H1N1
2 55.35 3.26 6.75 36.30 9.04
1) Season: week 27 to week 26 the following year. 2) Pandemic influenza A(H1N1) 2009/10
Figure 1 Weekly Danish temperatures 1994/5 to 2009/10.
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Page 3 of 13age groups (a = 0, 1-4, 5-14, 15-44, 45-64, 65-74, 75-84,
85+ years) and gender (g):
E(MRa,g,wk)=E ( D a,g,wk/Na,g,wk)=E ( D a,g,wk)/Na,g,wk
where MR is the Mortality Rate, D number of all-
cause deaths and N is the none-stochastic size of the
population.
We used an additive Poisson regression model (link =
id) with 1/population-size as offset parameter and allow-
ing for overdispersion. For each age group and gender,
the model for E(D) could formally be described as
(omitting regression constants and parameters to be
estimated):
E(D) = spline(wk)+
sin

2 π

365.25/7

∗ wk

+c o s

2 π

365.25/7

∗ wk

+
sin

4 π

365.25/7

∗ wk

+c o s

4 π

365.25/7

∗ wk

+

s

wkIA + wcwk +w w wk +s c wk +s w wk+

s

wk−1IA + wcwk−1 +w w wk−1 +s c wk−1 +s w wk−1 +

epi
where the terms spline(wk) and the sine and cosine
terms express the baseline with trend and seasonality.
Trend was included as a cubic spline, and both a yearly
and half-yearly seasonal cycles were included as sines
and cosines. Impact of influenza activity (IA) may be
heterogeneous between seasons [23]. Hence, IA was
included separately for each season s (season: week 27
to week 26 the following year): ∑s∑wkIA. In the primary
analysis IA was expressed as proportion of weekly ILI-
consultations. Impacts of extreme temperatures were
separated in weeks with extreme summer or winter tem-
peratures, and include as the four variables: wc = winter
cold, ww = winter warm, sc = summer cold and sw =
summer warm (Figure 1). Further, deaths may be
delayed relative to when IA was registered at a consulta-
tion or relative to when the temperature was extreme.
Therefore, IA and extreme temperature event from the
preceding week were also included. Finally, to compen-
sate major unexplained peaks (outliers), residuals greater
than 1.5 standard deviations, lasting 3 week or more
and not explained by IA or extreme temperatures were
included as artificial epidemic-parameters to compensate
these (∑epi).
In order to obtain a more conservative estimation of
influenza-associated mortality (rather than ILI), we
applied an influenza-index to express influenza activity
(IA), created by reducing the ILI consultation percen-
tage for each season. This was done by multiplying the
ILI consultation percentage in a specific season with a
normal distribution, with mean and standard derivation
as for the ILI percentage over the same season. This
reduces the ILI percentage in the beginning and end of
the season, and maintains the ILI percentage at the
height of the season (Figure 2).
In the final model only trend and seasonal yearly or
half-yearly cycles were included if they contributed on a
5% level (p < 0.05). Sensitivity to the temperature
thresholds was investigatedb yv a r y i n gt h et h r e s h o l d s .
Results are reported for the age groups 0-4, 5-14, 15-64
and 65+ years of age and for both sexes together.
Hence, the results were adjusted for heterogeneities in
pattern and variations between ages and genders. All
analyses were done using Stata 11 MP.
Results
The model fitted well in all age and gender strata (exam-
ined on deviances [24]), and there were no indications of
either heteroskedasticity or residual autocorrelation
(examined in correlograms). The results of the model are
shown in Figure 3 for age groups and gender.
We found mortality to be associated with both ILI-
activity and extreme temperatures (Figure 4).
The model included a baseline with both a yearly sea-
sonal cycle and a half-yearly cycle, and the half-yearly
cycle contributed on a 5% level in most strata. However,
this was not due to a summer peaks; the half-year cycle
created a seasonal pattern where the total seasonal cycle
reaches its maximum earlier than for a symmetric yearly
cycle, and as a consequence the decline became pro-
longed (baseline in Figure 4), corresponding more to the
appearance of slightly asymmetric “epidemic curves”
including a long right tail.
ILI-attributable mortality
Over the seasons 1994/5 to 2009/10 the total median
number of excess deaths per season attributable to ILI was
1879 (range: 306-5251) and the median mortality rate
(MR) per 100,000 population was 35.4 (range: 5.6-100.0),
table 2. Most of the ILI associated deaths per year was
among elderly ≥ 65 years (median 87.9%) and adults 15-64
years (median 11.4%). There were nearly no ILI associated
excess deaths among children (median 4 deaths for 0-4
years and -1 for 5-14 years of age), table 2.
Among adults, 15-64 years, there was an estimated
annual number of ILI-associated deaths of 286 (range:
-185 to 531) and the MR per 100,000 was 8.0 (range:
-5.3 to 15.0). Among persons aged 65 the median num-
ber of deaths was 1738 (range: 365 to 4723) correspond-
ing to a MR per 100,000 of 206.7 (range: 44.4 to 593.6).
All estimates were adjusted for variations over age and
between genders.
Influenza-associated mortality
Not all reported ILI-cases were influenza. Hence, we
reduced the ILI consultation percentage according to a pat-
tern that reflected influenza-transmission (Figure 3). Com-
pared to the total ILI-attributable number of deaths, this
reduced the median total number of excess deaths with
Nielsen et al. BMC Infectious Diseases 2011, 11:350
http://www.biomedcentral.com/1471-2334/11/350
Page 4 of 13around 25% to 1420 (range: -8 to 3810) per season per
100,000, and MR to 26.4 (range: -0.1 to 72.6) (Table 3).
Overall, we estimated that 82.0% of the influenza-associated
deaths were among elderly aged 65 years.
Temperature associated mortality
With our definition of a week having an extreme tem-
perature, 38.5% of the weeks experienced extreme tem-
perature (warm: 18.7%, cold: 19.8%) with a median
extreme temperature of 1.4 (range: 0.3-4.1) degrees;
warm: 1.5 (range: 0.4-4.1) degrees, cold: 1.3 (range: 0.3-
3.2) degrees. Increasing the thresholds (minimum and
maximum weekly temperatures) with up to 1 degree did
not change the results substantially. Increasing the
thresholds further reduced weeks with extreme tempera-
tures seriously and therefore affected the results.
A yearly median of 39 deaths (range: -162 to 273) could
be attributed to extreme ambient temperature, this corre-
sponded to a MR per 100,000 of 0.7 (range: -3.0 to 5.2).
These estimates were adjusted for variations over age and
between genders (Table 4). The impact of extreme tem-
peratures on mortality varied between benign (life saving)
and malign (increased mortality) effects over the seasons,
except among adults (15-64 years of age) where only
malign effects of extreme temperatures were estimated.
Further, a summer and winter differentiation in the
impact of warm and cold temperatures was observed,
with a benign effect of extreme cold during summer and
the opposite in winter. For extreme warm temperatures
it was the other way around (Table 5).
Discussion
Over the seasons 1994/5 to 2009/10 we found a median
all-cause mortality rate of 35.4 (range: 5.6-100.0) per sea-
son per 100,000 attributable to ILI for all ages and all inha-
bitants in Denmark, adjusted for trend, seasonality,
extreme temperatures and heterogeneities between age
groups and genders. Most of the mortality attributable to
influenza was among the elderly (88%). In the younger age
groups (< 65) there were seasons with an estimated benign
impact of circulating influenza (negative mortality rates).
This might have been due to few deaths and as a conse-
quence low statistical power. However, some of the nega-
tive estimates had narrow confidence intervals below zero
and cannot be ignored. We believe the benign impact of
circulating influenza in the population is due to changes in
Figure 2 Influenza like illness consultation percentage and the influenza-index.
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Page 5 of 13care seeking behaviour (goes earlier to the doctor, stay
home) due to knowledge of circulating influenza e.g. from
the press.
The median all-cause mortality rate attributable to
influenza for Denmark was within the range of estimates
from Germany, USA, Italy and Canada based on all-
cause mortality (Table 6) (range: 10 to 90 deaths per
season per 100,000). However, it is important to under-
line that these estimates were obtained using different
models and different periods.
Figure 3 Final model.
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the elderly with 80-90% of influenza related deaths
among persons aged 65 [14,6,25,26,15]. We estimated
the median Danish ILI-attributable mortality rate for
persons aged 65 to 206.7 (range: 44.4 to 593.6), corre-
sponding to 88% of all ILI deaths. Hence, our estimate
of the all-cause mortality attributable to circulating
influenza for persons aged 65 was within the range of
estimates from other countries (table 6).
Surveillance of ILI, will include respiratory infections
caused by other pathogens than influenza virus that may
be perceived as influenza-like illness. Hence, excess
Figure 4 Mortality associated with both ILI-activity and extreme temperatures.
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Page 7 of 13mortality attributable to circulating influenza will over-
estimate mortality associated to influenza. Therefore, PI
as cause of death has been used to estimate influenza-
associated mortality [25,6,4,15,10]. Using PI-specific
mortality has been found to reduce mortality attributa-
ble to circulating influenza with 38% among Swiss
elderly (60+) [9], and 40% for all ages in Canada [27]
compared to estimates based on all-cause mortality.
However, for various reasons, estimates based on PI as
cause of death may tend to under-estimate influenza-
associated mortality. Death due to influenza, or where
influenza was an important component in the chain of
events that lead to the death, may not be coded as
respiratory, but rather as cardiac or related to other
complications of severe illness.
We estimated mortality attributable to ILI directly as a
parameter in our model. To obtain estimates of influenza-
associated mortality, we could have used data from labora-
tory based surveillance instead of ILI. However, the
virological surveillance of influenza in Denmark is not suffi-
ciently systematic and detailed to be used directly as a para-
meter to model influenza-associated mortality. Although
samples are collected by the sentinel practitioners, they
usually collect only three times in a season, which means
that the samples do not reflect the amount of circulating
influenza, i.e. are not suitable for modelling. Likewise, data
on clinical samples from hospitals are, except for the 2009/
10 pandemic, few in numbers for many seasons. We there-
f o r eu s e dap r o x yt od o w n g r a d eI L It oi n f l u e n z aa s
described above, and estimated an all-cause influenza-asso-
ciated mortality of 26.4 (range: -0.1 to 72.6) per season per
100,000, corresponding to a 25% lower mortality compared
to ILI-estimates, and slightly higher than PI-associated
mortality reported from other countries (table 6). There-
fore, with mortality attributable to ILI being an over-esti-
mate and PI-associated mortality probably an under-
estimate our estimate, using the influenza-index, may well
be a realistic estimate of influenza-associated mortality.
Table 2 Excess mortality related to Influenza Like Illness, by season and age group
Season
1 Death Mortality
2 Death Mortality
2 Death Mortality
2 Death Mortality
2 Death Mortality
2
Age: All ages 0-4 years 5-14 years 15-64 years Aged 65
1994/95 1812 34.73 (31.80;37.65) 20 5.94 (2.90;8.99) 7 1.21 (0.36;2.05) -185 -5.26 (-6.97;-3.54) 1970 246.72
(229.23;264.21)
1995/96 5252 100.04
(97.22;102.86)
10 2.88 (0.51;5.25) -12 -2.16 (-2.83;-
1.49)
531 15.04
(13.26;16.82)
4723 593.64
(576.84;610.43)
1996/97 2555 48.43 (45.69;51.17) 13 3.69 (1.19;6.20) 10 1.64 (0.85;2.44) 285 8.05 (6.22;9.88) 2247 283.27
(267.05;299.49)
1997/98 2287 43.20 (40.65;45.76) 4 1.28 (-0.89;3.46) -9 -1.51 (-2.23;-
0.78)
364 10.26 (8.76;11.76) 1928 243.52
(227.85;259.19)
1998/99 4477 84.26 (81.81;86.71) -3 -0.73 (-2.95;1.49) 19 2.97 (2.23;3.71) 478 13.43
(12.01;14.85)
3983 503.84
(488.70;518.98)
1999/00 2125 39.87 (37.55;42.19) -10 -2.99 (-5.10;-
0.88)
-5 -0.73 (-1.41;-
0.05)
220 6.18 (4.63;7.73) 1920 242.87
(228.89;256.85)
2000/01 1706 31.89 (29.19;34.58) 38 11.19
(8.58;13.80)
1 0.11 (-0.60;0.81) 220 6.17 (4.67;7.67) 1447 182.75
(165.90;199.61)
2001/02 2615 48.71 (46.34;51.09) 19 5.71 (3.43;7.99) -5 -0.68 (-1.24;-
0.12)
304 8.51 (7.09;9.93) 2296 288.98
(274.30;303.65)
2002/03 1672 31.06 (28.72;33.41) 3 0.98 (-1.24;3.21) -13 -1.87 (-2.45;-
1.30)
159 4.45 (3.04;5.87) 1523 190.66
(176.19;205.12)
2003/04 1946 36.05 (33.74;38.36) 21 6.36 (4.00;8.72) 0 -0.04 (-0.67;0.60) 287 8.02 (6.65;9.39) 1638 203.58
(189.39;217.77)
2004/05 1414 26.13 (23.60;28.66) -15 -4.61 (-6.98;-
2.23)
-6 -0.89 (-1.45;-
0.33)
225 6.30 (4.76;7.83) 1210 148.85
(133.49;164.22)
2005/06 306 5.63 (3.06;8.20) -6 -1.72 (-3.97;0.53) 5 0.74 (0.21;1.27) -59 -1.65 (-3-29;-0.01) 365 44.35 (28.99;59.70)
2006/07 1718 33.37 (30.86;35.87) 0 0.03 (-2.32;2.37) 5 0.71 (0.09;1.32) 287 10.74 (9.17;12.32) 1426 170.70
(155.89;185.51)
2007/08 1486 27.13 (24.84;29.42) 14 4.16 (1.97;6.36) -1 -0.13 (-0.69;0.44) 397 10.98 (9.67;12.30) 1076 126.12
(112.56;139.69)
2008/09 2113 38.35 (36.09;40.62) -11 -3.42 (-5.48;-
1.35)
-4 -0.65 (-1.22;-
0.08)
291 8.02 (6.76;9.28) 1838 209.83
(196.61;223.06)
2009/10 541 9.77 (7.41;12.14) -3 -0.85 (-2.79;1.08) 10 1.50 (0.85;2.15) 55 1.50 (0.02;2.99) 479 53.01 (39.84;66.18)
Median 1879 35.39 4 1.13 -1 -0.08 286 8.02 1738 206.71
1) Season: week 27 to week 26 the following year. 2) Deaths per 100,000 per year
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higher in season where the dominating influenza is
H3N2, compared to H1N1 seasons [5,28,6,7,25]. We
found particular high excess mortality in the two influ-
enza A(H3N2) seasons of 1995/96 and 1998/99, whereas
the influenza A(H3N2) season of 2005/6 and the 2009
i n f l u e n z aA ( H 1 N 1 )p a n d e m i ch a dn o n eo ro n l ym o d e s t
impact on mortality. In addition, there has been a
declining trend in influenza related mortality since the
1990’s( F i g u r e5 ) .T h i st r e n dr e m a i n se v e na f t e r
Table 3 Excess mortality associated to Influenza expressed by the influenza-index, by season and age group
Season
1 Death Mortality
2 Death Mortality
2 Death Mortality
2 Death Mortality
2 Death Mortality
2
Age: All ages 0-4 years 5-14 years 15-64 years Aged 65
1994/95 877 16.82 (13.99;19.64) -1 -0.22 (-2.96;2.51) 0 -0.00 (-0.81;0.80) -233 -6.63 (-8.22;-5.03) 1111 139.16 (122.16;156.16)
1995/96 3810 72.58 (70.05;75.12) 7 2.14 (-0.15;4.43) -10 -1.68 (-2.31;-1.05) 360 10.17 (8.72;11.62) 3453 434.03 (418.61;449.45)
1996/97 1827 34.64 (31.85;37.42) 3 0.74 (-1.72;3.19) 7 1.15 (0.37;1.92) 271 7.65 (5.92;9.39) 1546 194.95 (178.19;211.71)
1997/98 1432 27.04 (24.53;29.56) 0 -0.02 (-2.19;2.14) -10 -1.60 (-2.30;-0.89) 276 7.77 (6.33;9.21) 1166 147.26 (131.79;162.73)
1998/99 3488 65.65 (63.23;68.08) -11 -3.31 (-5.40;-1.22) 16 2.53 (1.77;3.28) 386 10.84 (9.45;12.24) 3098 391.91 (376.92;406.89)
1999/00 1802 33.80 (31.46;36.14) -6 -1.83 (-3.94;0.28) -3 -0.40 (-1.07;0.27) 158 4.43 (2.93;5.93) 1653 209.09 (194.87;223.31)
2000/01 1072 20.03 (17.32;22.74) 21 6.17 (2.77;9.57) 0 -0.03 (-0.74;0.67) 120 3.37 (1.92;4.82) 931 117.53 (100.49;134.57)
2001/02 2002 37.30 (34.99;39.62) 16 4.70 (2.47;6.93) -2 -0.32 (0.87;0.24) 232 6.51 (5.18;7.83) 1756 221.02 (206.59;235.44)
2002/03 952 17.68 (15.46;19.90) 3 0.93 (-1.28;3.14) -5 -0.74 (-1.43;-0.06) 122 3.41 (2.01;4.81) 832 104.20 (90.66;177.75)
2003/04 1409 26.10 (23.79;28.41) 17 5.12 (2.77;7.47) 1 0.18 (-0.43;0.79) 207 5.79 (4.45;7.13) 1183 147.07 (132.78;161.35)
2004/05 988 18.25 (15.66;20.84) -13 -3.85 (-6.32;-1.37) -7 -1.05 (-1.59;-0.52) 152 4.25 (2.69;5.81) 855 105.24 (89.47;212.01)
2005/06 -8 -0.14 (-2.68;2.40) -6 -1.82 (-4.02;0.37) 5 0.68 (0.17;1.19) -67 -1.86 (-3.59;-0.14) 61 7.37 (-7.60;22.33)
2006/07 1385 25.41 (22.93;27.90) 0 0.04 (-2.32;2.40) 3 0.48 (-0.17;1.13) 281 7.82 (6.31;9.33) 1100 131.60 (116.82;146.39)
2007/08 1465 26.76 (24.51;29.00) 17 5.20 (3.08;7.31) -1 -0.21 (-0.75;0.34) 287 7.95 (6.66;9.24) 1162 136.23 (122.91;149.56)
2008/09 1744 31.65 (29.41;33.89) -10 -3.19 (-5.23;-1.15) -4 -0.57 (-1.13;-0.00) 215 5.92 (4.68;7.15) 1543 176.22 (163.11;189.33)
2009/10 121 2.19 (-0.19;4.57) -2 -0.64 (-2-54;1.26) 8 1.17 (0.52;1.83) -11 -0.29 (-1.72;1.14) 126 13.93 (0.58;27.29)
Median 1420 26.43 0 0.01 -1 -0.12 211 5.86 1164 143.11
1) Season: week 27 to week 26 the following year. 2) Deaths per 100,000 per year
Table 4 Excess mortality associated to extreme ambient temperatures, by season and age group
Season
1 Death Mortality
2 Death Mortality
2 Death Mortality
2 Death Mortality
2 Death Mortality
2
Age: All ages 0-4 years 5-14 years 15-64 years Aged 65
1994/95 7 0.14 (-2.97;3.24) -1 -0.19 (-3.88;3.49) -2 -0.36 (-1.30;0.57) 50 1.42 (-0.48;3.32) -40 -5.03 (-23.47;13.41)
1995/96 273 5.20 (1.88;8.52) 5 1.36 (-1.37;4.09) 0 0.07 (-0.61;0.74) 85 2.39 (0.22;4.57) 183 23.05 (3.43;42.67)
1996/97 86 1.63 (-1.54;4.80) 2 0.56 (-2.39;3.51) -2 -0.34 (-1.27;0.58) 70 1.99 (-0.26;4.24) 16 1.99 (-16.46;20.44)
1997/98 117 2.22 (-0.70;5.13) 1 0.21 (-2.29;2.71) -1 -0.24 (-1.09;0.61) 56 1.58 (-0.17;3.34) 62 7.80 (-9.98;25.59)
1998/99 112 2.28 (-0.49;5.06) 3 0.94 (-1.71;3.60) -1 -0.17 (-1.09;0.74) 56 1.59 (-0.04;3.21) 63 7.93 (-9.16;25.02)
1999/00 -17 -0.32 (-2.91;2.26) -1 -0.28 (-2.78;2.22) -2 -0.34 (-1.14;0.46) 37 1.03 (-0.82;2.87) -51 -6.40 (-21.66;8.85)
2000/01 -162 -3.02 (-6.18;0.13) -2 -0.67 (-3.88;2.53) -3 -0.45 (-1.31;0.41) 46 1.29 (-0.43;3.01) -203 -25.57 (-45.35;-5.79)
2001/02 -139 -2.58 (-5.30;0.13) -4 -1.13 (-3.95;1.69) -2 -0.29 (-0.92;0.35) 32 0.90 (-0.80;2.59) -165 -20.76 (-37.40;-4.12)
2002/03 241 4.47 (1.81;7.14) 4 1.13 (-1.55;3.81) 0 -0.05 (-0.69;0.59) 69 1.94 (0.29;3.60) 167 21.03 (4.72;37.33)
2003/04 64 1.19 (-1.30;3.68) 1 0.25 (-2.53;3.02) -2 -0.26 (-1.00;0.48) 56 1.56 (0.09;3.04) 9 1.15 (-14.18;16.48)
2004/05 14 0.25 (-2.67;3.17) 2 0.52 (-2.30;3.34) -3 -0.44 (-1.06;0.19) 62 1.72 (-0.04;3.48) -47 -5.77 (-23.54;12.00)
2005/06 174 3.21 (0.13;6.29) 4 1.25 (-1.48;3.97) 0 -0.03 (-0.65;0.58) 74 2.05 (0.04;4.07) 97 11.77 (-6.50;30.04)
2006/07 -135 -2.47 (-5.32;0.38) -5 -1.44 (-4.16;1.28) -3 -0.39 (-1.08;0.30) 50 1.39 (-0.47;3.25) -177 -21.22 (-37.93;-4.52)
2007/08 -146 -2.66 (-5.27;-0.05) -3 -0.89 (-3.47;1.68) -3 -0.39 (-1.04;0.26) 48 1.33 (-0.17;2.83) -188 -22.06 (-37.51;-6.61)
2008/09 -8 -0.14 (-2.79;2.50) 0 -0.12 (-2.60;2.36) -2 -0.23 (-0.89;043) 32 0.89 (-0.54;2.33) -38 -4.39 (-19.91;11.13)
2009/10 164 2.97 (0.32;5.62) 2 0.66 (-1.50;2.81) 0 0.06 (-0.71;0.83) 61 1.67 (-0.01;3.36) 101 11.17 (-3.55;25.88)
Median 39 0.72 1 0.23 -2 -0.27 56 1.57 -15 -1.62
1) Season: week 27 to week 26 the following year. 2) Deaths per 100,000 per year
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Page 9 of 13Table 5 Temperature associated mortality differentiated on summer and winter, all ages
Season
1 Summer (week 14 to 39) Winter (week 40 to 13)
Cold Warm Cold Warm
Death Mortality
2 Weeks Death Mortality
2 Weeks Death Mortality
2 Weeks Death Mortality
2 Weeks
1994/95 -30 -0.58 (-3.78;2.62) 7 67 1.29 (-1.87;4.45) 5 84 1.62 (-1.56;4.79) 4 -114 -2.19 (-5.38;1.00) 15
1995/96 -46 -0.88 (-4.23;2.48) 10 44 0.84 (-2.52;4.19) 6 313 5.97 (2.62;9.33) 17 -38 -0.73 (-4.09;2.62) 5
1996/97 -79 -1.50 (-4.74;1.75) 14 39 0.75 (-2.52;4.01) 6 199 3.78 (0.54;7.01) 12 -74 -1.40 (-4.66;1.87) 7
1997/98 -6 -0.11 (-3.11;2.88) 2 94 1.78 (-1.18;4.74) 11 116 2.19 (-0.78;5.15) 6 -87 -1.64 (-4.63;1.35) 7
1998/99 -65 -1.22 (-4.06;1.63) 15 -2 -0.03 (-2.89;2.82) 2 215 4.05 (1.22;6.87) 11 -28 -0.52 (-3.36;2.32) 5
1999/00 -22 -0.41 (-3.07;2.26) 3 72 1.36 (-1.26;3.98) 9 20 0.37 (2.30;3.04) 2 -88 -1.65 (-4.30;1.01) 9
2000/01 -87 -1.63 (-4.84;1.57) 15 0 0.00 (-3.24;3.24) 0 86 1.61 (1.62;4.83) 6 -160 -3.00 (-6.20;0.20) 14
2001/02 -19 -0.35 (-3.13;2.43) 6 50 0.94 (-1.83;3.71) 11 7 0.12 (-2.67;2.91) 1 177 -3.29 (-6.03;-0.56) 14
2002/03 -28 -0.51 (-3.23;2.21) 4 62 1.15 (-1.57;3.87) 9 235 4.36 (1.65;7.07) 15 -29 -0.53 (-3.27;2.21) 3
2003/04 -41 -0.76 (-3.36;1.84) 6 61 1.14 (-1.47;3.75) 9 124 2.30 (-0.29;4.89) 8 -80 -1.49 (-4.06;1.09) 6
2004/05 -105 -1.95 (-4.91;1.02) 15 20 0.37 (-2.64;3.38) 3 154 2.84 (-0.15;5.84) 9 -55 -1.01 (-4.01;1.98) 3
2005/06 -82 -1.51 (-4.60;1.58) 12 0 0.00 (-3.11;3.11) 0 286 5.27 (2.17;8.37) 14 -30 -0.55 (-3.65;2.56) 3
2006/07 -10 -0.18 (-3.11;2.76) 1 107 1.97 (-0.91;4.85) 15 0 0.00 (-2.94;2.94) 0 -232 -4.26 (-7.18;-1.35) 17
2007/08 -62 -1.14 (-3.78;1.51) 12 23 0.41 (-2.25;3.02) 5 83 1.51 (-1.15;4.17) 7 -189 -3.45 (-6.11;-0.79) 15
2008/09 -28 -0.51 (-3.21;2.18) 7 38 0.70 (-1.98;3.38) 6 53 0.96 (-1.73;3.65) 4 -71 -1.30 (-3.99;1.40) 10
2009/10 -22 -0.40 (-3.10;2.30) 7 56 1.02 (-1.67;3.70) 9 179 3.23 (0.05;5.91) 11 -49 -0.88 (-3.58;1.83) 6
Median -36 -0.67 7 47 0.89 6 119 2.24 8 -77 -1 7
1) Season: week 27 to week 26 the following year. 2) Deaths per 100,000 per year
Table 6 Mortality related to influenza
Country Period Age group Mortality per 100,000 Method Reference
West Germany
Germany
1984/85-1994/95
1990/91-2000/01
All 16.1 (range: 2.2;35.7)
17.4 (range: 5.9;44.2)
All cause Zucs 2005 [28]
USA 1972/73-2002/03 All 65.0 (range: 0;134.2)
72.4 (range11.7;144.7)
All cause Thompson 2009 [3]
Canada 1997-2000
2000-2004
All 15,6
5.8 (vaccination)
All cause Kwong 2008 [12]
Italy 1969-2001 All 23.4 (H3N2)/7.4 (H1N1) All cause Rizzo 2007 [6]
Canada 1989/90-1998/99 All 13.1 All cause Schanzer 2007 [27]
South Africa
USA
1998-2005
1997/98-2004/05
65+ 340
112
All cause Cohen 2010 [7]
Czech Republic 1982/83-1999/00 65+ 26.0 (range: -8.9;60.4) All cause Kyncl 2005 [30]
Netherlands 1992-1996
1996-2003
65+ 131 (95% CI: 123-139)
105 (95% CI: 99-111) (vaccination)
All cause Jansen 2008 [31]
Hong Kong 1996-1999 65+ 93.2 (95% CI: 78.4-107.7)
136.1 (95% CI: 83.7-188.4)
All cause Wong 2004 [15]
Portugal 2008/09 65+ 18 All cause Nogueira 2009 [8]
Switzerland 1969/70-1998/99
1988/89-1998/99
60+ 67.2 (range: 20.9;209,5)
152.8 (range: 66.3;293.3)
69.5 (range: 32.6;234,5)
187.1 (range: 121.0;356.0)
115.3 (range: 60.6;226.9)
All cause Brinkhof 2006 [9]
Netherlands 1967-1989 60+ 82 All cause Sprenger 1993 [32]
USA 1976/77-2006/07 All 9.0 (range: 1.4;16.7)
2.4 (range: 0.4;5.1)
RC
PI
MMWR 2010 [25]
Italy 1969-2001 All 4.5 (H3N2)/0.8 (H1N1) PI Rizzo 2007 [6]
USA
France
Australia
1972-1997 All 2.6 (range: 0;6.3)
3.9 (range: 0;18.3)
1.3 (range: 0;7.5)
PI Viboud 2004 [4]
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Page 10 of 13excluding the low-mortality 2005/6 H3N2 season and
the 2009/10 H1N1 pandemic, although not that strong.
The reasons for this trend are not obvious, but
increased use of vaccines for the elderly, genetic drift of
the virus as well as herd immunity in the population
may contribute.
Over the seasons 1994/5 to 2009/10 we found an all-
cause median mortality rate of 0.7 (range: -3.0 to 5.2) per
season per 100,000 attributable to periods with extreme
temperatures for all ages and all inhabitants in Denmark,
adjusted for trend, seasonality, influenza activity and het-
erogeneities between age groups and genders. However,
this consists of both periods with extreme cold and heat,
and covers both summer and winter. Perhaps not sur-
prisingly, there seems to be a pattern where periods with
cold weather in the summer is life saving, while heat may
cost lives. In the winter season warm periods saves lives,
while cold cost lives.
We have proposed and evaluated a methodology and
statistical model usable to estimate excess mortality asso-
ciated to two potential explanatory factors, ILI and
extreme temperatures based on all-cause mortality. The
model fitted data well and all-cause mortality has pre-
viously been found to be the most complete and accurate
in assessing the total impact of influenza on mortality [29].
More explanatory factors may be included in the model
like for example infection with RSV [11], other cause of
acute respiratory illnesses and invasive pneumococcal dis-
ease, to get more detailed estimates of variations in excess
mortality. A limitation of the model is potential interac-
tions between the explanatory factors, which cannot be
easily implemented in the model; especially with more
Table 6 Mortality related to influenza (Continued)
South Africa
USA
1998-2005
1997/98-2004/05
65+ 42
22
PI Cohen 2010 [7]
Hong Kong 1996-1999 65+ 16.7 (95% CI: 9.8-23.7)
39.3 (95% CI: 21.4-57.3)
PI Wong 2004 [15]
France 1984-2004 65+ 1.4 (range: 0;9.4) PI Denoeud 2007 [10]
RC: Respiratory and circulatory cause’s incl. pneumonia and influenza. Vaccination: After introduction of vaccination programme
Figure 5 Influenza(ILI)-attributable mortality, according to dominant type of influenza.
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Page 11 of 13than two explanatory factors. As influenza virus circulates
simultaneously with other respiratory infections, ILI may
include infections caused by other pathogens than influ-
enza virus and may as such be an overestimation of circu-
lating influenza. Denmark does not have systematic
ongoing laboratory surveillance of influenza, but among
influenza-samples received at the reference laboratory at
Statens Serum Institut, the proportion of influenza positive
samples is typically low in the beginning and end of the
season, and highest around the peak of ILI. Our influenza-
index reflects this pattern Others have used PI cause-spe-
cific mortality as outcome, and our methodology gives
influenza-associated mortality that falls between the over-
estimation using all cause mortality and the under-estima-
tion using PI cause specific mortality. Further, it has the
advantage of depending only on easily obtainable data
namely weekly number of all-cause deaths, temperature,
and ILI.
Conclusions
We have shown that it is doable to model seasonally
fluctuations in mortality related to ILI or influenza and
to extreme ambient temperatures based on all-cause
mortality. This is promising, as all-cause data is easier
to obtain than cause-specific data, and not subject to
coding bias. It is recognised that coding practices will be
affected by awareness and media reports. However, it is
of interest to apply our methodology to other datasets
in order to validate it further. We also advocate that
laboratory based influenza surveillance should be rein-
forced in order to better estimate the proportion of
severe respiratory illness that are caused by influenza.
This may serve as a more appropriate independent vari-
able in future multivariable models. Finally, it is worth
noting that influenza mortality has tended to decline
and studies of the effect of in particular influenza vacci-
nation policies on this trend are needed.
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